StocksA › AMBA

Ambarella, Inc. (AMBA) — Earnings Call X-Ray

Our AI read all 38 of AMBA's earnings calls (2015–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q1 2026 · sign up to see
Previous Call Grade
B+
Q3 2025
Expected Move
🔒
next 45 days · members
Calls Analyzed
38
2015–2025
Avg Candor
6.9/9
evasion 3/9
Guidance RaisedHigh CandorSkeptic ReassuredCritic AmmunitionFounder-LedEarly Product, Fast GrowthRaising PricesDemand Accelerating

Call-by-call analysis

🔒 Q1 2026 earnings call 2025-05-29 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q1 2026 call grade is ready
The full 37-point AI read of AMBA's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

B+ Q3 2025 earnings call 2024-11-26 move ±14.4%

Management raised guidance against accelerating demand. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: acceleratingMargins: stableBacklog: shrinkingPricing: raisingHeadcount: growingCapex: flat 10 analysts · 20 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growthFounder-led
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B+ Q2 2025 earnings call 2024-08-27 move ±21%

Management raised guidance against accelerating demand. The delivery was unusually candid, rich in specifics.

Guidance: raisedDemand: acceleratingMargins: stableBacklog: growingPricing: raisingHeadcount: growingCapex: decreasing 9 analysts · 19 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead✓ Early product, fast growth
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 3/9
Promotion 5/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B Q1 2025 earnings call 2024-05-30 move ±25.4%

Management held guidance steady against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: growingPricing: stableHeadcount: growingCapex: increasing 9 analysts · 21 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead✓ Early product, fast growth
Candor 7/9
Specificity 8/9
Evasion 1/9
Confidence 8/9
Uncertainty 3/9
Promotion 6/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q4 2024 earnings call 2024-02-27 move ±8.3%

Management held guidance steady against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: contractingPricing: stableHeadcount: flatCapex: decreasing 7 analysts · 14 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead✓ Early product, fast growth
Candor 8/9
Specificity 8/9
Evasion 3/9
Confidence 6/9
Uncertainty 4/9
Promotion 5/9
Stress 3/9
Complexity 5/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q3 2024 earnings call 2023-11-30 move ±9%

Management held guidance steady against steady demand. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: stableBacklog: growingCapex: flat 6 analysts · 11 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growthFounder-led
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q2 2024 earnings call 2023-08-29 move ±26.6%

Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: slowingMargins: contractingBacklog: shrinkingPricing: raisingHeadcount: cutting 10 analysts · 20 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Early product, fast growthFounder-ledHidden segment
Candor 8/9
Specificity 7/9
Evasion 2/9
Confidence 5/9
Uncertainty 6/9
Promotion 4/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q1 2024 earnings call 2023-05-30 move ±18.9%

Management held guidance steady against slowing demand. The delivery was unusually candid.

Guidance: maintainedDemand: slowingMargins: stableBacklog: shrinkingPricing: stableHeadcount: flatCapex: flat 12 analysts · 17 questions
⚑ Critic ammunition⚑ Question left hanging✓ Early product, fast growthFounder-ledHidden segmentDirection beats results
Candor 7/9
Specificity 6/9
Evasion 3/9
Confidence 6/9
Uncertainty 6/9
Promotion 5/9
Stress 2/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q4 2023 2023-02-28 D loweredslowingcontracting 7/9 4/9
Q3 2023 2022-12-01 D loweredslowingstable 7/9 4/9
Q2 2023 2022-08-30 D maintainedslowingstable 7/9 3/9
Q1 2023 2022-05-31 D loweredmixedstable 7/9 3/9
Q4 2022 2022-02-28 C maintainedstableexpanding 8/9 2/9
Q3 2022 2021-11-30 C+ maintainedmixedexpanding 7/9 3/9
Q2 2022 2021-08-31 B+ raisedacceleratingexpanding 7/9 3/9
Q1 2022 2021-06-02 B+ raisedacceleratingexpanding 7/9 2/9
Q4 2021 2021-03-03 B raisedacceleratingstable 7/9 3/9
Q3 2021 2020-11-24 B raisedacceleratingcontracting 6/9 3/9
Q2 2021 2020-09-02 C maintainedmixedexpanding 7/9 4/9
Q1 2021 2020-06-02 F loweredmixedstable 7/9 4/9
Q4 2019 2020-03-03 B raisedmixedcontracting 7/9 2/9
Q3 2020 2019-11-25 D loweredmixedstable 6/9 2/9
Q2 2020 2019-08-29 C+ raisedacceleratingcontracting 6/9 3/9
Q1 2020 2019-06-05 D raisedmixedcontracting 6/9 5/9
Q4 2018 2019-03-06 D maintainedmixedcontracting 6/9 4/9
Q3 2019 2018-11-29 F loweredmixedcontracting 7/9 4/9
Q2 2019 2018-08-31 D loweredslowingcontracting 7/9 2/9
Q1 2019 2018-06-05 D loweredmixedcontracting 7/9 3/9
Q4 2018 2018-03-01 D loweredmixedcontracting 7/9 2/9
Q3 2018 2017-11-30 D loweredmixedcontracting 7/9 2/9
Q2 2018 2017-08-31 D loweredmixedcontracting 7/9 2/9
Q1 2018 2017-06-06 D maintainedmixedcontracting 7/9 3/9
Q4 2017 2017-03-01 F loweredmixedcontracting 7/9 5/9
Q3 2017 2016-12-01 F loweredmixedstable 7/9 4/9
Q2 2017 2016-09-01 C maintainedmixedexpanding 7/9 2/9
Q1 2017 2016-06-02 F loweredmixedcontracting 7/9 4/9
Q4 2016 2016-03-04 D loweredmixedcontracting 7/9 4/9
Q3 2016 2015-12-03 F loweredmixedcontracting 6/9 4/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of AMBA's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

D Q3 2023 earnings call 2022-12-01

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAN · The Aaron's Company, IncAAWW · Atlas Air Worldwide HoldABAX · ABAXISABCB · Ameris BancorpABM · ABM Industries IncorporaACBI · Atlantic Capital Bancsha

AMAT   All “A” companies    AMBC

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.